Management of acquired resistance to EGFR TKI–targeted therapy in advanced non-small cell lung cancer

詳細情報 詳細情報について

• CRID

  1362262943545808384

• DOI

  10.1186/s12943-018-0777-1

• ISSN

  14764598

• Web Site

  http://link.springer.com/content/pdf/10.1186/s12943-018-0777-1.pdf

• データソース種別

  • Crossref